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By use of a new assay method based on HPLC, GlcNAc-transferase III, IV and V activities were determined 
in HL-60 cells, differentiated HL-60 cells and normal myeloid cells. Differentiation along the monocytic 
lineage with la,25dihydroxyvitamin Ds resulted in increased GlcNAc-transferase IV and decreased 
GlcNAc-transferase III activity. Differentiation along the myeloid lineage with retinoic acid resulted in a 
decrease in GlcNAc-transferase III activity. Although differentiated HL-6d cells show a changed GlcNAc- 
transferase pattern, they do not resemble normal myeloid cells. Macrophages and granulocytes are charac- 
terized by a very low level of GlcNAc-transferase III activity whereas differentiated HL-60 cells still contain 
this activity. This is the first demonstration of GlcNAc-transferase IV and V activity in a human cell. 
N-Acetylglucosaminyltransferase III; N-Acetylglucosaminyltransferase IV; N-Acetylglucosaminyltransferase V; 
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1. INTRODUCTION 
Cells of the human promyelocytic leukemic cell- 
line HL-60 can be induced to undergo myeloid dif- 
ferentiation by retinoic acid [l-4] or DMSO [l-4] 
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mannose; Ara-C, cytosine-arabinoside; DMSO, 
dimethyl sulfoxide; vit D3, lcu,25-dihydroxyvitamin D3; 
HPLC, high-performance liquid chromatography; Mes, 
2-(N-morpholino)ethanesulfonic acid. Enzymes: UDP- 
GlcNAc: Mar@1 +4GlcNAc-R pl-+4-N-acetylglucosa- 
minyltransferase, GlcNAc-transferase III (EC 2.4.1.144); 
UDP-GlcNAc: Mancvl-+3Man-R @l +CN-acetylglu- 
cosaminyltransferase, GlcNAc-transferase IV (EC 
2.4.1.145); UDP-GlcNAc: Mancv1-t6Man-R PI -+6-N- 
acetylglucosaminyltransferase, GlcNAc-transferase V 
(EC 2.4.1.155) 
and monocytic differentiation by vit D3 [S] and, 
Ara-C [6]. The asparagine-N-linked oligosac- 
charides found on the cell surface of HL-60 cells 
differ in size and structure from those found on the 
cell surface of more differentiated cells [7,8]. 
Mizoguchi and co-workers [8] suggested that these 
changes are due to a changed expression of N- 
acetylglucosaminyltransferases, involved in the 
biosynthesis of tri- and tetraantennary N-linked 
chains, bisected structures and elongated chains. 
To obtain more insight into the enzymatic basis for 
the differentiation-dependent structural altera- 
tions, we assayed the activities of GlcNAc- 
transferase III, IV and V (see fig.1) in HL-60 cells 
and differentiated cells by use of a new method 
based on HPLC. 
2. MATERIALS AND METHODS 
Neutrophilic granulocytes were a gift from Dr L. 
Koenderman (Central Laboratory of the 
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Netherlands Red Cross Transfusion Service, 
Amsterdam, The Netherlands). Human peritoneal 
macrophages were spun down at low speed from 
the fluid obtained after peritoneal dialysis. Human 
promyelocytic HL-60 cells were cultured in the 
presence or absence of differentiation-inducing 
agents as described in [9]. Cell pellets were 
homogenized at 0°C in 10 mM sodium cacodylate, 
pH 7.0, using a Potter-Elvehjem homogenizer. 
Protein concentration was determined according 
to Lowry et al. [lo]. Reference oligosaccharides bi, 
bis, tri and tri’ (see fig.1) were derived by P- 
galactosidase (jack bean) digestion from the cor- 
responding ,&4_galactosylated compounds, which 
were kindly donated by Dr G. Strecker (Universite 
de Lille, Villeneuve d’Ascq, France). UDP- 
[14C]GlcNAc (149 Ci/mol) was obtained from The 
Radiochemical Centre, Amersham. 
2.1. Assay of GlcNAc-transferases III, IV and V 
Incubation mixtures contained 12.5 pmol Mes 
buffer, pH 7.0, 20 prnol GlcNAc, 1.25 pmol 
MnC12, 0.5% Triton X-100, 50 nmol oligosac- 
charide bi, 200 nmol UDP-[14C]GlcNAc (5 Ci/ 
mol) and cell lysate (0.2-1.2 mg protein) in a 
volutne of 100 ~1. The mixtures were incubated for 
18 h at 37°C. The reaction was stopped by adding 
1 ml Hz0 and passing the mixture through a 
column of 1 ml Dowex l-X8, AC--form. The col- 
umn was washed twice with 0.5 ml Hz0 and the 
combined eluates were treated with NaBH4 for 1 h 
as described [ 1 I], lyophilized and analyzed by 
HPLC. 
2.2. HPLC 
The lyophilized material was dissolved in 200 pl 
H20. 30 ~1 of each sample was analyzed by HPLC 
on a column (4 x 250 mm) of Lichrosorb-NH2 
(Merck, Darmstadt), using a Spectra-Physics 
SP 8700 delivery system, equipped with a 
Rheodyne 7105 injection valve. Elution was car- 
ried out as indicated in the legend to fig.2. Frac- 
tions of 0.6 ml were collected and assayed for 
radioactivity. UV detection of standards was per- 
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Fig. 1. Product oligosaccharide structures (bis), (tri) and (tri’) formed by the action of GlcNAc-transferase III, IV and 
V on the acceptor oligosaccharide (bi), studied here. 
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formed with a Hewlett-Packard-1040 A diode ar- 
ray detector, controlled by Hewlett-Packard 85 
microcomputer. 
3. RESULTS 
By use of a new assay method based on HPLC, 
developed as will be described elsewhere, activities 
of GlcNAc-transferase III, IV and V (fig.1) were 
determined in normal myeloid cells and differen- 
tiated HL-60 cells. Activities of the three 
- 
-1.,,,. 
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Fig.2. Assay of GlcNAc-transferase III, IV and V 
activities by HPLC. Analyses were performed on a 
Lichrosorb-NH2 column. Elution was carried out at a 
flow rate of 2 ml amin-‘, using an acetonitrile 
(Lichrosolv grade)/15 mM potassium phosphate (pH 
5.2) mixture (4 : 1, v/v) with a linear gradient, decreasing 
the acetonitrile concentration by 0.2% min-‘. 
Transferase activities were measured in (A) 
macrophages, (B) HL-60 cells and (C) vit Ds-induced 
HL-60 cells. As acceptor oligosaccharide bi was used 
(fig.1). The arrows indicate the elution position of 
GakTl + fGlcNAc@l -+ 3Gal,&l+4Glc (1) and the reduced 
forms of compounds bi (2), tri (3), bis (4) and tri’ (5). 
transferases could be detected in one assay as il- 
lustrated in fig.2. A clear separation between the 
breakdown products of UDP-[14C]GlcNAc (elu- 
tion time O-15 min) and the individual transferase 
products was obtained. 
In macrophages GlcNAc-transferase IV and V 
activities could be detected (fig.2 and table 1). On- 
ly a residual activity of GlcNAc-transferase III was 
found. No GlcNAc-transferase activities were 
found in neutrophilic granulocytes (table 1). 
HL-60 cells appeared to contain a relatively high 
GlcNAc-transferase III activity in addition to 
lower activities of GlcNAc-transferase IV and V 
(table 1). HL-60 cells were also grown in the 
presence of vit DJ, Ara-C, retinoic acid and 
DMSO. Induction with Ara-C and DMSO had no 
significant effect on the activities of each of the 
GlcNAc-transferases. Comparable activities were 
found in control HL-60 cells and cells induced with 
these agents (table 1). Induction with vit D3, 
however, resulted in an increase in activity of 
GlcNAc-transferase IV with a concomitant 
decrease in GlcNAc-transferase III activity. After 
Table 1 
GlcNAc-transferase III, IV and V activities in normal 
myeloid and induced HL-60 cells 
Cell Activity of GlcNAc- 
transferase 
(pmol . mg-r protein. h-r) 
III IV V 
HL-60 cells 
control 162 12 46 
+ vit D3 37 164 22 
+ Ara-C 198 10 39 
+ retinoic acid 39 16 43 
+ DMSO 164 22 41 
Normal cells 
macrophages 5 40 42 
neutrophilic 
granulocytes cl Cl Cl 
HL-60 cells were grown for 4 days in the presence of 
lo-’ M vit Ds, Ara-C or retinoic acid or 1.25% DMSO 
[9]. Cell lysates were assayed for the different GlcNAc- 
transferase activities using oligosaccharide bi as an 
acceptor. Enzyme activities were assayed as described in 
section 2 and analyzed by HPLC as described in the 
legend to fig.1 
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induction with retinoic acid a reduction of 
GlcNAc-transferase III activity was seen, whereas 
the activities of GlcNAc-transferase IV and V re- 
mained essentially unchanged (table 1). Different 
ratios of GlcNAc-transferase activities in cells 
stimulated by vit D3 and retinoic acid compared to 
the other cells are the result of these changes. 
4. DISCUSSION 
The demonstration that differentiation of 
HL-60 cells is accompanied by changes in size and 
structure of their oligosaccharide chains [7,8] 
prompted us to study the activity levels of GlcNAc- 
transferase III, IV and V (fig.1) in these cells. 
Based on the occurrence of bisected structures in 
HL-60 cells it was suggested that the expression of 
GlcNAc-transferase III is unique for cells belong- 
ing to the myeloid lineage [S]. In accord with the 
structures we were able to detect relatively high 
GlcNAc-transferase III activity in the cell lysates. 
This enzyme was first described in hen oviduct [ 121 
and plays a key role in the synthesis of bisected N- 
glycans [13]. 
Upon induction of monocytic differentiation of 
HL-60 cells with vit Ds and myeloid differentiation 
with retinoic acid a dramatic decrease in the activi- 
ty of GlcNAc-transferase III was encountered. A 
still lower GlcNAc-transferase III activity was 
found in normal human macrophages, whereas the 
enzyme activity in granulocytes was below detec- 
tion. The latter observation, which ‘is consistent 
with the absence of bisected N-linked glycans on 
normal granulocytes [14,15], shows that the ex- 
pression of GlcNAc-transferase III is not a general 
feature of myeloid cells as was suggested by 
Mizoguchi et al. [8]. Rather, it might be 
characteristic for a certain stage of cell maturation 
or, alternatively, it might be associated with the 
malignant character of the HL-60 cells. 
Earlier bisected structures have been reported to 
occur in hepatomas, but to be absent in normal 
liver tissue [16]. In accord with this structural 
evidence expression of GlcNAc-transferase III was 
seen in a pre-cancerous stage of liver car- 
cinogenesis [ 171. This is yet another example where 
malignant transformation of cells is accompanied 
by a strong expression of this key glycosyl- 
transferase. 
Induction of myeloid differentiation of HL-60 
cells by DMSO did not result in gross changes in 
the activities of GlcNAc-transferases III, IV and 
V. This would suggest that the oligosaccharide 
chains of HL-60 cells before and after induction 
with this agent will not show major differences. In- 
deed, it has been reported that the oligosaccharide 
pattern of DMSO-induced cells is very similar to 
that of HL-60 cells [8]. 
This result might seem to conflict with the 
decrease of GlcNAc-transferase III activity upon 
induction of myeloid differentiation of HL-60 cells 
by retinoic acid. It is, however, known that DMSO 
and retinoic acid act in a different way [18]. The 
first agent acts on less mature cells than the second 
inducer. Moreover, the morphological changes ac- 
companying the differentiation process occur 
much faster under the influence of retinoic acid. 
Therefore, more pronounced changes in the levels 
of GlcNAc-transferases and consequently in the 
structures of cell surface oligosaccharides must be 
expected upon induction with retinoic acid. 
Although induction of myeloid differentiation 
of HL-60 cells did not result in gross changes in the 
activities of GlcNAc-transferase IV and V, a great- 
ly increased activity of GlcNAc-transferase IV was 
encountered upon vit Ds-induced monocytic dif- 
ferentiation. Normal macrophages also expressed 
a higher level of GlcNAc-transferase IV activity 
than uninduced HL-60 cells. Along with the 
decreased activity of GlcNAc-transferase III in vit 
D3-induced cells and macrophages, these results 
suggest that monocytic differentiation of HL-60 
cells is characterized by a shift from bisected 
oligosaccharide structures to tri- and tetraanten- 
nary glycans of the non-bisected type. 
No GlcNAc-transferase IV and V activity could 
be detected in granulocytes. Yet tri- and 
tetraantennary structures occur on these cells 
[ 14,151. A possible explanation is that these struc- 
tures are formed at certain precursor stages, before 
the GlcNAc-transferase activities are lost during 
subsequent maturation. Further work is required 
to verify this possibility. 
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